15.02.2024 | Letter to the Editor
Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2024
Einloggen, um Zugang zu erhalten